Detailed description page of ThPDB2
| This page displays user query in tabular form. |
10693 details |
| Primary information | |
|---|---|
| ID | 10693 |
| Therapeutic ID | Th1156 |
| Protein Name | Abarelix |
| Sequence | >Th1156_Abarelix XXXSYNLXPA |
| Molecular Weight | NA |
| Chemical Formula | NA |
| Isoelectric Point | NA |
| Hydrophobicity | NA |
| Melting point | NA |
| Half-life | 13.2 ± 3.2 days |
| Description | NA |
| Indication/Disease | NA |
| Pharmacodynamics | NA |
| Mechanism of Action | NA |
| Toxicity | NA |
| Metabolism | NA |
| Absorption | NA |
| NA | |
| Clearance | NA |
| Categories | Anti-Testosterone Agents |
| Patents Number | US6423686 |
| Date of Issue | 23-07-2002 |
| Date of Expiry | 6-Jul-2015 |
| Drug Interaction | NA |
| Target | Gonadotropin-releasing hormone receptor |
| Brand Name | NA |
| Company | NA |
| Brand Description | NA |
| Prescribed For | NA |
| Chemical Name | NA |
| Formulation | NA |
| Physical Appearance | NA |
| Route of Administration | NA |
| Recommended Dosage | NA |
| Contraindication | NA |
| Side Effects | NA |
| Useful Link 1 | NA |
| Useful Link 2 | NA |
| Remarks | NA |